Nefrocarnit injektionslosung用于继发性肉碱缺乏症。主要用于慢性肾衰长期血透病人因肉碱缺乏产生的一系列并发症状，临床表现如心肌病、骨骼肌病、心律失常、高脂血症，以及低血压和透析中肌痉挛等。
L-Carnitin losses with people which must undergo regularly a blood laundry (hemodialysis treatment)
•Active Ingredient
Levocarnitine
•Pharmaceutical form and contents
Nefrocarnit ® oral solution is available in bottles of 50 ml of Nefrocarnit® oral solution and 150 (3*50) ml of Nefrocarnit ® oral solution Nefrocarnit® injection solution is available original packs of 10 or 25 ampoules , each containing 5 ml of injection solution
•Mode of action
Nefrocarnit ® injection/oral solution is used in the treatment of levocarnitine deficiency in patients with DCD‌ (dialysis-related carnitine disorder) 1g of levocarnitine (3.3 ml of Nefrocarnit ® oral solution=1 measuring beaker) per day. On dayes with heamodialysis treatment, Nefrocarnit® oral solution should be taken after dialysis. For intravenous administration :At the end of each haemodialysis treatment,20 mg of levocarnitine per kg bw are administered by slow intravenous injection via the inserted reflux canula. As a rule ,1 to 2 ampoules are required.
10x1mg/5ml
30x1mg/5ml
50x1mg/5ml